Tokuda Hospital

At Tokuda Hospital in Sofia, research in cardiology focuses on persistent symptomatic atrial fibrillation and hypertrophic cardiomyopathy, with studies aimed at improving symptom control, reducing arrhythmia recurrence, and testing whether earlier intervention or new treatment approaches can offer better outcomes.

• Early treatment strategies for persistent atrial fibrillation
• Comparing catheter ablation with antiarrhythmic medication
• Relief of symptoms and functional limitations in hypertrophic cardiomyopathy

These trials explore both treatment effectiveness and patient quality of life, reflecting a strong interest in practical advances for heart rhythm disorders and structural heart disease.

The site’s gastroenterology and broader internal medicine research includes moderately to severely active Crohn's disease, chronic hepatitis B virus infection, and non-alcoholic steatohepatitis, with trials designed to evaluate new therapies, measure disease improvement, and better understand long-term safety in chronic inflammatory and liver conditions.

• Testing treatment options for Crohn’s disease
• Assessing antiviral control in chronic hepatitis B
• Evaluating therapy for non-alcoholic steatohepatitis and liver fibrosis

This area highlights the clinic’s involvement in diseases that affect the digestive tract, immune regulation, and liver health, where the goal is often to improve disease control and prevent progression.

Oncology research at Tokuda Hospital includes studies in diffuse large B-cell lymphoma, follicular lymphoma, ER+, HER2- metastatic breast cancer, and lung cancer, with a clear emphasis on testing new cancer treatments and comparing them with established standards of care.

• New treatment combinations for lymphoma
• Therapies for relapsed or untreated blood cancers
• Comparative studies in metastatic breast cancer and lung cancer

These trials are aimed at improving survival, response rates, and disease control in both solid tumors and hematologic malignancies.

The research portfolio also covers acute respiratory distress syndrome and metabolic liver disease, especially non-alcoholic steatohepatitis, showing interest in both severe acute illness and chronic metabolic complications.

• Supportive treatment for severe respiratory failure linked to infection
• Therapies targeting inflammation and fibrosis in liver disease
• Evaluating safety alongside clinical benefit in difficult-to-treat conditions

These studies focus on whether new interventions can improve outcomes in high-risk patients with serious breathing problems or progressive metabolic disease.

Immunology-focused research includes atopic dermatitis and multiple sclerosis, with trials centered on controlling chronic immune-mediated disease, reducing flares or progression, and evaluating longer-term treatment safety and flexibility.

• Improving skin disease control in atopic dermatitis
• Long-term safety follow-up in multiple sclerosis
• Adjusting treatment to match patient response

This reflects a broader commitment to immune-related disorders where the main goals are sustained symptom relief, safer maintenance therapy, and better everyday function.